Cite

HARVARD Citation

    Casan, J. et al. (2019). Dose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma: not yet the standard of care. Lancet. 6 (3), pp. e119-. [Online]. 
  
Back to record